JUZEN CHEMICAL CORPORATION

Juzen Chemistry has strengthened its nucleic acid pharmaceutical business this year, enabling support from lab-scale to commercial production for oligonucleotide CDMO business. With this expansion, we now offer a one-stop solution for research support, investigational drug manufacturing, and stable commercial product supply, similar to our existing capabilities for small molecules. Utilizing GMP-compliant quality standards and diverse synthetic techniques, we support the outsourcing of active pharmaceutical ingredient (API) manufacturing.